A targeted genetic testing for idiopathic ventricular fibrillation revealed a mutation in the desmoglein-2 (DSG2) gene involved in arrhythmogenic right ventricular cardiomyopathy (ARVC). This evidence concerns the gene DSG2 and paroxysmal familial ventricular fibrillation.